Abatacept in the Treatment of Uveitis
| Status: | Completed |
|---|---|
| Conditions: | Cervical Cancer, Ocular |
| Therapuetic Areas: | Oncology, Ophthalmology |
| Healthy: | No |
| Age Range: | 6 - Any |
| Updated: | 2/23/2019 |
| Start Date: | January 2012 |
| End Date: | June 2017 |
An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.
The purpose of this study is to assess the safety and efficacy of abatacept in the treatment
of uveitis.
of uveitis.
Inclusion Criteria:
- patients with vision-threatening autoimmune uveitis
- failure to respond to prednisone and at least one other systemic immunosuppressive, or
intolerance to such medications due to side effects
Exclusion Criteria:
- serious concomitant illness that could interfere with the subject's participation
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials
